VF
OLMA icon

Virtu Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Virtu Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,161
Closed -$539K – 2069
2026
Q1 		$539K Sell
36,161
-6,276
-15% -$140K 0.02% 549
2025
Q4 		$1.06M Buy
+42,437
New +$755K 0.04% 338
2023
Q2 		– Sell
-10,015
Closed -$35K – 1873
2023
Q1 		$35K Sell
10,015
-3,500
-26% -$14.3K ﹤0.01% 1155
2022
Q4 		$33K Buy
+13,515
New +$39.4K ﹤0.01% 1161

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Virtu Financial's OLMA Position: Q2 2026 in Review

Virtu Financial sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 36,161 shares — an estimated $539K sold.

Virtu Financial first reported a position in OLMA in Q4 2022 and held it in 4 quarters. The position peaked at $1.06M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Virtu Financial reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 36,161 Olema Pharmaceuticals shares in Q2 2026, an estimated $539K.
  • Virtu Financial first reported a position in Olema Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Virtu Financial's Olema Pharmaceuticals position peaked at $1.06M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.